Donepezil for anorexia nervosa, restrictive type
Treatments studied
Part of Mental health clinical trials.
This trial tests if a daily pill (donepezil) helps women with anorexia nervosa, specifically the restrictive type (where you limit food intake). The study aims to see if the drug improves weight or eating behaviors compared to a placebo (no active drug).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 65 years old.
- You have a diagnosis of anorexia nervosa, restrictive type (restricting food, not binge-eating or purging).
- Your body mass index (BMI) is between 15 and 18.5 kg/m².
- You are not currently taking psychiatric medications (like antidepressants) or have stopped within the last 3 weeks.
- You do not have other mental health conditions like schizophrenia, bipolar disorder, or bulimia.
- You are not pregnant, breastfeeding, and use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called donepezil, usually used for memory problems, can help people with anorexia nervosa break repetitive habits around food and eating. If it works, it might make it easier to change eating behaviors.
This trial compares donepezil (a medicine for Alzheimer’s symptoms) against a non-drug treatment plan. It aims to see which approach helps people with Alzheimer’s who still have measurable thinking ability and specific Alzheimer’s test results.
This Phase 2 study tests whether donepezil, along with structured cognitive (brain) training, can improve outcomes for people with alcohol use disorder. It will measure whether this combination helps after recent heavy drinking, while tracking safety over about 13 weeks.
This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.
This study tests whether a small, easy-to-swallow tablet of rivastigmine can help improve memory and thinking in people with moderate Alzheimer's disease. Rivastigmine is a common Alzheimer's medication that may help slow down memory loss.
This trial tests a new drug, NBI-1117567, for people with mild to moderate Alzheimer's disease who are already taking a standard Alzheimer's medication. The goal is to see if the new drug can help improve symptoms.
Hear when a new Anorexia Nervosa Restricting Type trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.